RA Capital

Ramaswamy
Favicon Fierce Biotech

Ramaswamy-backed Ambros launches with $125M to develop pain med

Ambros is using the money to fund a phase 3 trial of Abiogen's neridronate for Complex Regional Pain Syndrome type 1.
Angus Liu Dec 16, 2025 1:32pm
Illustration of two people shaking hands standing on money and a lightbulb

Sublingual psychedelic startup nets $60M for depression trials

Nov 8, 2022 7:30am
money private equity venture capital investment cash dollar sign investor

Getting Cerebral: VCs bet $40M on epilepsy implant development

Jul 5, 2022 8:55am